US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 41.100
  • +0.290+0.71%
Trading Jul 5 10:53 ET
2.51BMarket Cap-8876P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
649.46%23.64M
383.76%8.79M
316.73%4.28M
3,208.76%9.07M
Operating revenue
126.41%25.97M
227.56%77.43M
175.70%24.23M
425.30%22.5M
112.01%19.22M
665.62%11.47M
649.46%23.64M
383.76%8.79M
316.73%4.28M
3,208.76%9.07M
Cost of revenue
97.54%2.81M
336.10%9.3M
214.49%3.23M
385.31%2.41M
491.53%2.24M
517.83%1.42M
256.09%2.13M
335.59%1.03M
123.87%497K
175.91%378K
Gross profit
130.49%23.16M
216.79%68.13M
170.56%21M
430.55%20.09M
95.50%16.99M
692.43%10.05M
741.68%21.51M
390.96%7.76M
369.85%3.79M
6,241.61%8.69M
Operating expense
160.55%163.05M
25.83%252.48M
24.87%62.27M
48.76%64.05M
18.23%63.59M
15.98%62.58M
16.25%200.66M
-5.15%49.87M
-4.42%43.05M
32.57%53.78M
Selling and administrative expenses
39.57%34.38M
27.71%117.53M
23.02%32.37M
38.91%30.48M
34.57%30.05M
14.85%24.63M
34.38%92.03M
25.34%26.32M
25.31%21.94M
44.38%22.33M
Research and development costs
239.08%128.67M
24.23%134.95M
26.94%29.89M
58.98%33.57M
6.63%33.54M
16.72%37.95M
4.32%108.63M
-25.42%23.55M
-23.32%21.12M
25.30%31.46M
Operating profit
-166.29%-139.89M
-2.90%-184.36M
1.99%-41.27M
-11.93%-43.95M
-3.34%-46.6M
0.30%-52.53M
-5.35%-179.16M
17.43%-42.1M
11.24%-39.27M
-11.54%-45.1M
Net non-operating interest income expense
-550.92%-1.71M
104.52%53K
-2,536.67%-731K
125.90%317K
-135.96%-82K
136.88%379K
-362.19%-1.17M
-77.61%30K
-986.96%-1.22M
985.71%228K
Non-operating interest income
-11.45%3.05M
246.12%13.95M
25.58%3.82M
276.74%3.47M
1,075.55%3.22M
2,050.00%3.44M
801.34%4.03M
2,169.40%3.04M
566.67%920K
1,204.76%274K
Non-operating interest expense
55.34%4.76M
167.10%13.89M
51.11%4.55M
46.88%3.15M
7,080.43%3.3M
--3.06M
--5.2M
--3.01M
--2.14M
--46K
Other net income (expense)
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
-100.79%-790K
-420K
-370K
-133K
Other non- operating income (expenses)
2,040.74%524K
124.05%190K
233.10%559K
57.03%-159K
87.22%-17K
88.41%-27K
-100.79%-790K
---420K
---370K
---133K
Income before tax
-170.36%-141.07M
-1.65%-184.11M
2.49%-41.44M
-7.18%-43.8M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
16.44%-42.49M
7.35%-40.86M
-11.36%-45M
Income tax
300K
564K
196K
368K
0
0
0
0
Net income
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45M
Net income continuous Operations
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45M
Minority interest income
Net income attributable to the parent company
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45M
Basic earnings per share
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
-147.86%-3.47
11.76%-0.75
-12.86%-0.79
-27.14%-0.89
Diluted earnings per share
-155.43%-2.35
7.78%-3.2
6.67%-0.7
3.80%-0.76
7.87%-0.82
12.38%-0.92
-147.86%-3.47
11.76%-0.75
-12.86%-0.79
-27.14%-0.89
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M649.46%23.64M383.76%8.79M316.73%4.28M3,208.76%9.07M
Operating revenue 126.41%25.97M227.56%77.43M175.70%24.23M425.30%22.5M112.01%19.22M665.62%11.47M649.46%23.64M383.76%8.79M316.73%4.28M3,208.76%9.07M
Cost of revenue 97.54%2.81M336.10%9.3M214.49%3.23M385.31%2.41M491.53%2.24M517.83%1.42M256.09%2.13M335.59%1.03M123.87%497K175.91%378K
Gross profit 130.49%23.16M216.79%68.13M170.56%21M430.55%20.09M95.50%16.99M692.43%10.05M741.68%21.51M390.96%7.76M369.85%3.79M6,241.61%8.69M
Operating expense 160.55%163.05M25.83%252.48M24.87%62.27M48.76%64.05M18.23%63.59M15.98%62.58M16.25%200.66M-5.15%49.87M-4.42%43.05M32.57%53.78M
Selling and administrative expenses 39.57%34.38M27.71%117.53M23.02%32.37M38.91%30.48M34.57%30.05M14.85%24.63M34.38%92.03M25.34%26.32M25.31%21.94M44.38%22.33M
Research and development costs 239.08%128.67M24.23%134.95M26.94%29.89M58.98%33.57M6.63%33.54M16.72%37.95M4.32%108.63M-25.42%23.55M-23.32%21.12M25.30%31.46M
Operating profit -166.29%-139.89M-2.90%-184.36M1.99%-41.27M-11.93%-43.95M-3.34%-46.6M0.30%-52.53M-5.35%-179.16M17.43%-42.1M11.24%-39.27M-11.54%-45.1M
Net non-operating interest income expense -550.92%-1.71M104.52%53K-2,536.67%-731K125.90%317K-135.96%-82K136.88%379K-362.19%-1.17M-77.61%30K-986.96%-1.22M985.71%228K
Non-operating interest income -11.45%3.05M246.12%13.95M25.58%3.82M276.74%3.47M1,075.55%3.22M2,050.00%3.44M801.34%4.03M2,169.40%3.04M566.67%920K1,204.76%274K
Non-operating interest expense 55.34%4.76M167.10%13.89M51.11%4.55M46.88%3.15M7,080.43%3.3M--3.06M--5.2M--3.01M--2.14M--46K
Other net income (expense) 2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K-100.79%-790K-420K-370K-133K
Other non- operating income (expenses) 2,040.74%524K124.05%190K233.10%559K57.03%-159K87.22%-17K88.41%-27K-100.79%-790K---420K---370K---133K
Income before tax -170.36%-141.07M-1.65%-184.11M2.49%-41.44M-7.18%-43.8M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M16.44%-42.49M7.35%-40.86M-11.36%-45M
Income tax 300K564K196K368K0000
Net income -170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M-27.16%-45M
Net income continuous Operations -170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M-27.16%-45M
Minority interest income
Net income attributable to the parent company -170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M-27.16%-45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M-27.16%-45M
Basic earnings per share -155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92-147.86%-3.4711.76%-0.75-12.86%-0.79-27.14%-0.89
Diluted earnings per share -155.43%-2.357.78%-3.26.67%-0.73.80%-0.767.87%-0.8212.38%-0.92-147.86%-3.4711.76%-0.75-12.86%-0.79-27.14%-0.89
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg